Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 26,908 shares at $36.15 ($973K) on 2024-02-22, disclosed to the SEC on 2024-02-23.
Open-market sale of $973k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.15 | 13,454 | $486K | 50.0% |
| 2 | $36.15 | 13,454 | $486K | 50.0% |
| Total | $36.15 avg | 26,908 | $973K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |